1Radakovic-Fijan S,Fumsinn-Friedl AM,Honigsmann H,et al.Oral dexamethasone pulse treatment for vitilig[J].J Am Acad Dermatol,2001,44(5):814-817.
2Arroyo MP,Tift L.Vitiligo therapy:where are we now?[J].J Drugs Dermatol,2003,2(4):404-408.
3McNeely W,Goa KL.5-Methoxypsoralen.A review of its effects in psoriasis and vitiligo[J].Drugs,1998,56(4):667-690.
4Plettenberg H,Assmann T,Ruzicka T.Childhood vitiligo and tacrolimus:immunomodulating treatment for an autoimmune disease[J].Arch Dermatol,2003,139(5):651-654.
5Lepe V,Moncada B,Castanedo-Cazares JP,et al.A doubleblind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo[J].Arch Dermatol,2003,139(5):581-585.
6Molokhia MM,Portnoy B.Neutron activation analysis of trace elements in skin.Ⅶ.Copper and zinc in vitiligo,moles and seborrhoeic warts[J].Br J Dermatol,1973,88(4):347-353.
7Kumaran MS,Kaur I,Kumar B.Effect of topical calcipotriol,betamethasone dipropionate and their combination in the treatment of localized vitiligo[J].J Eur Acad Dermatol Venereol,2006,20(3):269-273.
8Ermis O,Alpsoy E,Cetin L,et al.Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study[J].Br J Dermatol,2001,145(3):472-475.
9Parsad D,Saini R,Nagpal R.Calcipotriol in vitiligo:a preliminary study[J].Pediatr Dermatol,1999,16(4):317-320.
